T. Rowe Price Associates »

Tenax Therapeutics shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Tenax Therapeutics (TENX) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Tenax Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tenax Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tenax Therapeutics by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2024-09-30 $84k 24k 3.50

More positions owned by T. Rowe Price Associates

Microsoft Corp Comm Stk (MSFT)
Apple Comm Stk (AAPL)
Nvidia Corporation Comm Stk (NVDA)
Amazon Comm Stk (AMZN)
Meta Platforms Comm Stk (META)
Eli Lilly & Co Comm Stk (LLY)
Alphabet Comm Stk (GOOGL)
Unitedhealth Group Comm Stk (UNH)
Alphabet Comm Stk (GOOG)
Visa Comm Stk (V)
Mastercard Incorporated Comm Stk (MA)
Netflix Comm Stk (NFLX)
Tesla Comm Stk (TSLA)
Intuitive Surgical Comm Stk (ISRG)
Thermo Fisher Scientific Comm Stk (TMO)

View all positions for T. Rowe Price Associates

Top funds holding Tenax Therapeutics

BVF
VR Adviser
Vestal Point Capital
Stonepine Capital Management
T. Rowe Price Associates
Dimensional Fund Advisors
Geode Capital Management
Lynx1 Capital Management
Qube Research & Technologies
Tower Research Capital
BlackRock
BlackRock
Morgan Stanley
Bank of America Corporation
Hanson McClain Advisors

View all funds holding Tenax Therapeutics